Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Fonar - Where is it going? -- Ignore unavailable to you. Want to Upgrade?

To: FRANK ROSSI who wrote (18794)	9/10/2003 1:22:41 AM
From: David C. Burns	Respond to of 19354

Rheumatology News Features FONAR Stand-Up MRI; ''Scanning Patients Flat on Their Backs Really Isn't Doing the Job'' MELVILLE, N.Y.--(BUSINESS WIRE)--Sept. 10, 2003--FONAR Corporation (Nasdaq:FONR), The MRI Specialist(TM), reported today that the July/August 2003 issue of Rheumatology News featured a news article entitled "Stand-Up MRI Catches Missed Spinal Pathology," referring to the FONAR Stand-Up(TM) MRI, the Company's whole body Upright(TM) imaging system. The article covered a technical paper delivered by J. Randy Jinkins, M.D. at the annual meeting of the American Society for Neuroradiology in Washington, D.C. in May 2003. Dr. Jinkins is a senior research fellow with FONAR and a Professor of Radiology at Drexel University, Philadelphia, Pennsylvania. The article, written by senior writer Jeff Evans, opens with a direct quote from Dr. Jinkins' presentation: "MRI images taken when a patient is upright can make a world of difference when evaluating a patient's spinal pathology before and after surgery." According to Dr. Jinkins, "Scanning patients flat on their backs really isn't doing the job." Dr. Jinkins stated that images taken while the patient is lying down can seriously underestimate the degree of degenerative spinal pathology. He further claimed that an MRI performed while the patient is in a standing (or sitting) position, however, can help identify position-related, clinically relevant spinal pathology to ensure that an accurate diagnosis is made. The Rheumatology News article covered two remarkable patient case studies that compelled Dr. Jinkins to conclude, "Such scenarios suggest that the patient's true diagnosis was missed on standard (lie-down) MRI." Dr. Jinkins was also quoted as saying, "It has always surprised me that when we speak about failed back surgery, it's always the surgeon that seems to be at fault." Perhaps the real source of failed back surgery is in selecting an insensitive modality for preoperative assessment of the spine, reported Rheumatology News. Rheumatology News, an independent newspaper located in Rockville, MD, which is published six times a year for rheumatologists and other physicians treating rheumatologic conditions, informs its readers about clinical developments that will impact the care of patients. Early alerts on the latest studies in rheumatoid arthritis, osteoarthritis, and musculoskeletal and immune-mediated disorders are delivered by skilled reporters who attend medical meetings, monitor the deliberations of the Food and Drug Administration advisory committees, and speak with the thought-leaders in patient care. For thousands of specialists, Rheumatology News is a must-read. Their Web site is: www2.erheumatologynews.com. A photocopy of the article is available upon request from FONAR. MRI Specialist, Stand-Up, Upright, Position Imaging and pMRI are trademarks of FONAR Corporation. Be sure to visit FONAR's Web site for Company product and investor information: www.FONAR.com This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission. CONTACT: FONAR Corporation Daniel Culver / David Terry, 631-694-2929 Fax: 631-390-9540 www.FONAR.com SOURCE: FONAR Corporation

To: FRANK ROSSI who wrote (18794)	9/18/2003 11:47:49 AM
From: JakeStraw	Respond to of 19354

finance.yahoo.com

To: FRANK ROSSI who wrote (18794)	10/1/2003 1:56:04 PM
From: JakeStraw	Read Replies (1) \| Respond to of 19354

FONR still using monopoly money and diluting existing shareholders - "During the year ended June 30, 2003, we issued 5,433,077 shares of our common stock primarily in connection with the payment of vendors and suppliers of goods and services to the Company. The greater number of these shares were used in lieu of cash to pay the costs of manufacturing the Company's MRI scanners. In addition, we issued 15,000 shares of our common stock in connection with a repayment of a note payable in the aggregate amount of $21,750." biz.yahoo.com